BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38409850)

  • 1. Genomic analysis of primary epithelial neoplasms of the seminal vesicle identifies a subset of mucinous cystic tumours driven by KRAS mutations.
    Collins K; Galea LA; Foroughi F; Siegmund SE; Anderson WJ; Appu S; Idrees MT; Ulbright TM; Acosta AM
    Histopathology; 2024 Jun; 84(7):1192-1198. PubMed ID: 38409850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
    Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
    Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation profile of high-grade appendiceal mucinous neoplasm.
    Liao X; Vavinskaya V; Sun K; Hao Y; Li X; Valasek M; Xu R; Polydorides AD; Houldsworth J; Harpaz N
    Histopathology; 2020 Feb; 76(3):461-469. PubMed ID: 31491041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours.
    Sieben NL; Macropoulos P; Roemen GM; Kolkman-Uljee SM; Jan Fleuren G; Houmadi R; Diss T; Warren B; Al Adnani M; De Goeij AP; Krausz T; Flanagan AM
    J Pathol; 2004 Mar; 202(3):336-40. PubMed ID: 14991899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes.
    Basturk O; Tan M; Bhanot U; Allen P; Adsay V; Scott SN; Shah R; Berger MF; Askan G; Dikoglu E; Jobanputra V; Wrzeszczynski KO; Sigel C; Iacobuzio-Donahue C; Klimstra DS
    Mod Pathol; 2016 Sep; 29(9):1058-69. PubMed ID: 27282351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.
    Mackenzie R; Kommoss S; Winterhoff BJ; Kipp BR; Garcia JJ; Voss J; Halling K; Karnezis A; Senz J; Yang W; Prigge ES; Reuschenbach M; Doeberitz MV; Gilks BC; Huntsman DG; Bakkum-Gamez J; McAlpine JN; Anglesio MS
    BMC Cancer; 2015 May; 15():415. PubMed ID: 25986173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and clinicopathological features of appendiceal mucinous neoplasms.
    Yanai Y; Saito T; Hayashi T; Akazawa Y; Yatagai N; Tsuyama S; Tomita S; Hirai S; Ogura K; Matsumoto T; Wada R; Yao T
    Virchows Arch; 2021 Mar; 478(3):413-426. PubMed ID: 32821969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multipoint Kras oncogene mutations potentially indicate mucinous carcinoma on the entire spectrum of mucinous ovarian neoplasms.
    Lee YJ; Lee MY; Ruan A; Chen CK; Liu HP; Wang CJ; Chao WR; Han CP
    Oncotarget; 2016 Dec; 7(50):82097-82103. PubMed ID: 27888800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Characterization of Low- and High-Grade Pancreatic Mucinous Cystic Neoplasms Reveals Recurrent KRAS Alterations in "High-Risk" Lesions.
    Conner JR; Mariño-Enríquez A; Mino-Kenudson M; Garcia E; Pitman MB; Sholl LM; Srivastava A; Doyle LA
    Pancreas; 2017; 46(5):665-671. PubMed ID: 28196015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-grade mucinous lesion of the seminal vesicle: the counterpart of low-grade appendiceal mucinous neoplasm?
    Galea LA; Acosta AM; Appu S
    Histopathology; 2023 Jan; 82(2):365-367. PubMed ID: 36110052
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlation of molecular and morphological features of appendiceal epithelial neoplasms.
    Tsai JH; Yang CY; Yuan RH; Jeng YM
    Histopathology; 2019 Oct; 75(4):468-477. PubMed ID: 31111538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Genetic Analysis of Ovarian Brenner Tumors and Associated Mucinous Epithelial Neoplasms: High Variant Concordance and Identification of Mutually Exclusive RAS Driver Mutations and MYC Amplification.
    Tafe LJ; Muller KE; Ananda G; Mitchell T; Spotlow V; Patterson SE; Tsongalis GJ; Mockus SM
    Am J Pathol; 2016 Mar; 186(3):671-7. PubMed ID: 26797085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer.
    Nodin B; Zendehrokh N; Sundström M; Jirström K
    Diagn Pathol; 2013 Jun; 8():106. PubMed ID: 23800114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two types of primary mucinous ovarian tumors can be distinguished based on their origin.
    Simons M; Simmer F; Bulten J; Ligtenberg MJ; Hollema H; van Vliet S; de Voer RM; Kamping EJ; van Essen DF; Ylstra B; Schwartz LE; Wang Y; Massuger LF; Nagtegaal ID; Kurman RJ
    Mod Pathol; 2020 Apr; 33(4):722-733. PubMed ID: 31695154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract.
    Mirkovic J; McFarland M; Garcia E; Sholl LM; Lindeman N; MacConaill L; Dong F; Hirsch M; Nucci MR; Quick CM; Crum CP; McCluggage WG; Howitt BE
    Am J Surg Pathol; 2018 Feb; 42(2):227-233. PubMed ID: 28984674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed epithelial-stromal tumor (MEST) of seminal vesicle: a proposal for unified nomenclature.
    Reikie BA; Yilmaz A; Medlicott S; Trpkov K
    Adv Anat Pathol; 2015 Mar; 22(2):113-20. PubMed ID: 25664946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of c-myc and mutation of the KRAS gene in patients with ovarian mucinous tumors.
    Li XS; Sun J; He XL
    Genet Mol Res; 2015 Sep; 14(3):10752-9. PubMed ID: 26400304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary retroperitoneal mucinous cystic neoplasm of borderline malignancy with
    Son SM; Woo CG; Yun SJ; Lee OJ
    J Int Med Res; 2023 May; 51(5):3000605231172469. PubMed ID: 37198972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.
    Shim HS; Kenudson M; Zheng Z; Liebers M; Cha YJ; Hoang Ho Q; Onozato M; Phi Le L; Heist RS; Iafrate AJ
    J Thorac Oncol; 2015 Aug; 10(8):1156-62. PubMed ID: 26200269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Impact of KRAS and GNAS Analysis Added to CEA and Cytology in Pancreatic Cystic Fluid Obtained by EUS-FNA.
    Faias S; Duarte M; Albuquerque C; da Silva JP; Fonseca R; Roque R; Dias Pereira A; Chaves P; Cravo M
    Dig Dis Sci; 2018 Sep; 63(9):2351-2361. PubMed ID: 29796909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.